NGL Fine-Chem Limited (NSE:NGLFINE)
India · Delayed Price · Currency is INR 2,229.80
+97.20 (4.56%)
Apr 6, 2026, 3:29 PM IST
NGL Fine-Chem Market Cap
NGL Fine-Chem has a market cap or net worth of 13.76 billion as of April 6, 2026. Its market cap has increased by 84.90% in one year.
Market Cap
13.76B
Enterprise Value
14.09B
Revenue
4.47B
Ranking
n/a
PE Ratio
38.91
Stock Price
2,229.80
Market Cap Chart
Since December 24, 2004, NGL Fine-Chem's market cap has increased from 80.40M to 13.76B, an increase of 17,020.20%. That is a compound annual growth rate of 27.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 13.76B | 58.13% |
| Dec 31, 2025 | 8.70B | -21.72% |
| Dec 31, 2024 | 11.12B | -19.33% |
| Dec 29, 2023 | 13.79B | 44.38% |
| Dec 30, 2022 | 9.55B | -42.81% |
| Dec 31, 2021 | 16.70B | 140.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.07T |
| Divi's Laboratories | 1.55T |
| Apollo Hospitals Enterprise | 1.06T |
| Cipla | 963.20B |
| Windlas Biotech | 16.11B |
| Shalby | 14.98B |
| Beta Drugs | 14.00B |
| Suraksha Diagnostic | 13.03B |